Company Filing History:
2 out of 536 
1 out of 4 
1 out of 832,912 Years Active: 2019-2023
Title: Ma Luo: Innovator in HIV-1 Research
Introduction
Ma Luo is a prominent inventor based in Winnipeg, Canada. She has made significant contributions to the field of HIV research, focusing on innovative methods to induce immune responses against the virus. With a total of 4 patents to her name, her work is paving the way for more effective vaccine strategies.
Latest Patents
Luo's latest patents include groundbreaking methods for inducing immune responses against HIV-1. One of her notable inventions involves expression systems comprising nucleic acids encoding HIV-1 protease cleavage site polypeptides. This method aims to generate a lower magnitude, narrowly focused immune response that targets specific CD8+ T cells. By concentrating on the 12 protease cleavage sites, her approach seeks to eliminate founder viruses without triggering inflammatory responses that could activate more CD4+ T cells, which are vulnerable to HIV-1 infection.
Career Highlights
Throughout her career, Ma Luo has worked with various esteemed organizations. Notably, she has collaborated with Her Majesty the Queen in Right of Canada, as represented by the Minister, and the Minister of Health. Her work in these institutions has allowed her to further her research and contribute to public health initiatives.
Collaborations
[This section has been skipped due to space constraints.]
Conclusion
Ma Luo's innovative research and patents are crucial in the fight against HIV-1. Her focused approach to immune response could lead to more effective vaccines and ultimately save lives.